Challenges in preclinical characterization of nanomedicines
- In: SYMPOSIUM: SAFETY OF NANOMEDICINES: REALITY CHECK? on Tuesday, 15 April 2014, 13:00-14:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: DOBROVOLSKAIA, Marina (Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Researc, CRTP/NCL, Frederick, md, United States of America)
Background: Nanomedicine is rapidly growing field. Many nanoformulations have been granted regulatory approval for use in medical applications, while many more are in various phases of preclinical and clinical development. Aims: To review experience of NCI-Nanotechnology Characterization Laboratory with preclinical characterization of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.